Related Articles
Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: A useful tool in tumor therapy management
Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer
Serum thymidine kinase 1 levels predict cancer‑free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer
Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.
Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer